Hepln-13

Overview

Hepln-13 is a potent and orally active Hepsin inhibitor with an IC 50 of 0.33 μM. Hepln-13 can be used for the research of metastatic prostate cancer .

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Urogenital Disease | Products > Disease Areas > Prostate Cancer | Products > Disease Areas > Urogenital Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > Ser/Thr Protease

Product Information

• Catalog No.: HY-118134
• CAS No.: 64369-13-7
• Molecular Formula: C17H13BrN2
• Molecular Weight: 325.20
• Purity: 99.34%
• Storage: 4°C, protect from light * In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)
• Solubility: ≥ 2.08 mg/mL (6.40 mM); Clear solution
• Availability: In-stock

Source

Original product source